Atlas Trials

Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients

Clinical trial NCT05040854 · UNKNOWN

Trial details

NCT number
NCT05040854
Sponsor
Centro Hospitalar Tondela-Viseu
Status
UNKNOWN
Study type
OBSERVATIONAL
Inflammatory Bowel Diseases
Start date
2021-07-01
Primary completion
2024-04-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.